Topics Consultation - Mandatory Reporting of ARs Draft Guidance Document for Industry - Reporting Adverse Reactions to Marketed Health Products Drug Effectiveness/ Outcomes Research Workshop Expert Advisory Panel on selective COX-2 inhibitors NSAIDs MedEffect Initiative Working Conference - Strengthening the Evaluation of Real World Drug Safety and Effectiveness

As part of its regulatory responsibility, Health Canada conducts consultations in the area of post-market surveillance, primarily adverse reaction reporting, of drugs and health products. Participants' comments and ideas contribute to the development of strategic priorities for these programs, helping us define what they should strive to achieve in the short, medium and long-term.

For more information on consultations undertaken by the Health Products and Food Branch, please visit the Office of Consumer and Public Involvement.